Impact of Polymyxin Resistance on Virulence and Fitness among Clinically Important Gram-Negative Bacteria. (June 2022)
- Record Type:
- Journal Article
- Title:
- Impact of Polymyxin Resistance on Virulence and Fitness among Clinically Important Gram-Negative Bacteria. (June 2022)
- Main Title:
- Impact of Polymyxin Resistance on Virulence and Fitness among Clinically Important Gram-Negative Bacteria
- Authors:
- Wang, Yuan
Luo, Qixia
Xiao, Tingting
Zhu, Yunying
Xiao, Yonghong - Abstract:
- Abstract: Humanity is facing an enormous and growing worldwide threat from the emergence of multi-drug-resistant (MDR) Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii . Polymyxin B and E (colistin) constitute the last-line therapies for treating MDR Gram-negative bacteria. Polymyxin is a cationic antibacterial peptide that can destroy the outer membrane of Gram-negative bacteria. With the increasing clinical application of polymyxin, however, there have been many reports of the occurrence of polymyxin-resistant Gram-negative bacteria. This resistance is mainly mediated by the modification or complete loss of lipopolysaccharide (LPS). LPS is also a virulence factor of Gram-negative bacteria, and alterations of LPS may correlate with virulence. Although it is generally believed that the biological costs associated with drug resistance may enable benign susceptible bacteria to overcome resistant bacteria when antibiotic pressure is reduced, some studies have shown that polymyxin-resistant bacteria are associated with higher virulence and greater fitness compared with their susceptible counterparts. To predict the development of polymyxin resistance and evaluate interventions for its mitigation, it is important to understand the relative biological cost of polymyxin resistance compared with susceptibility. The impact of polymyxin resistance mechanisms on the virulence and fitness of these three Gram-negative bacteria areAbstract: Humanity is facing an enormous and growing worldwide threat from the emergence of multi-drug-resistant (MDR) Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii . Polymyxin B and E (colistin) constitute the last-line therapies for treating MDR Gram-negative bacteria. Polymyxin is a cationic antibacterial peptide that can destroy the outer membrane of Gram-negative bacteria. With the increasing clinical application of polymyxin, however, there have been many reports of the occurrence of polymyxin-resistant Gram-negative bacteria. This resistance is mainly mediated by the modification or complete loss of lipopolysaccharide (LPS). LPS is also a virulence factor of Gram-negative bacteria, and alterations of LPS may correlate with virulence. Although it is generally believed that the biological costs associated with drug resistance may enable benign susceptible bacteria to overcome resistant bacteria when antibiotic pressure is reduced, some studies have shown that polymyxin-resistant bacteria are associated with higher virulence and greater fitness compared with their susceptible counterparts. To predict the development of polymyxin resistance and evaluate interventions for its mitigation, it is important to understand the relative biological cost of polymyxin resistance compared with susceptibility. The impact of polymyxin resistance mechanisms on the virulence and fitness of these three Gram-negative bacteria are summarized in this review. … (more)
- Is Part Of:
- Engineering. Volume 13(2022)
- Journal:
- Engineering
- Issue:
- Volume 13(2022)
- Issue Display:
- Volume 13, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 13
- Issue:
- 2022
- Issue Sort Value:
- 2022-0013-2022-0000
- Page Start:
- 178
- Page End:
- 185
- Publication Date:
- 2022-06
- Subjects:
- Polymyxin -- Resistance -- Virulence -- Fitness -- Gram-negative bacteria -- Acinetobacter baumannii -- Escherichia coli -- Klebsiella pneumoniae
Engineering -- Periodicals
Engineering -- China -- Periodicals
620.005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/20958099 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.eng.2020.11.005 ↗
- Languages:
- English
- ISSNs:
- 2095-8099
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22560.xml